Polyphron Secures $20M in Seed Funding to Pioneer "Artificial Human Biology" and Transform Preclinical Drug Discovery
The modern pharmaceutical industry is facing an unprecedented paradox. Thanks to breakthroughs in artificial intelligence, researchers and biotechnology companies can…
